Is it known whether metreleptin passes into human breast milk?

It is unknown whether metreleptin (Myalepta) or its metabolites pass into human breast milk, and risk to newborns or infants cannot be excluded; whether to stop breastfeeding or stop or avoid therapy must be decided by weighing breastfeeding benefits for the child against treatment benefits for the woman.